Literature DB >> 11257708

The oral efficacy of vardenafil hydrochloride for inducing penile erection in a conscious rabbit model.

E Bischoff1, U Niewoehner, H Haning, M Es Sayed, T Schenke, K H Schlemmer.   

Abstract

PURPOSE: Inhibiting cyclic guanosine monophosphate metabolism may induce penile erection during concomitant nitric oxide production. Vardenafil hydrochloride is a new, highly selective, potent cyclic guanosine monophosphate phosphodiesterase 5 inhibitor. We determined the oral effectiveness of vardenafil in a simple and quantitative conscious rabbit model.
MATERIALS AND METHODS: Vardenafil was given orally to conscious rabbits. Erection was assessed in a time dependent manner by measuring the length of the uncovered penile mucosa. Erection was evaluated in the absence and presence of intravenous sodium nitroprusside, a nitric oxide donor.
RESULTS: Vardenafil induced dose dependent penile erection in conscious rabbits after the oral administration of 1 to 30 mg./kg. The efficacy of vardenafil was potentiated and effective doses were significantly reduced by the simultaneous administration of sodium nitroprusside.
CONCLUSIONS: The effect of vardenafil on penile erection after oral administration was clearly demonstrated in the conscious rabbit model. The time course and early onset of activity indicate that it may be useful for treating erectile dysfunction. Potentiation of the effect by the nitric oxide donor sodium nitroprusside implies that it would have enhanced activity during sexual arousal, when nitric oxide is produced endogenously. The clinical development of this product for erectile dysfunction is proceeding.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11257708

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

Review 1.  Vardenafil.

Authors:  Douglas Ormrod; Stephanie E Easthope; David P Figgitt
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

2.  Solution structure of the cGMP binding GAF domain from phosphodiesterase 5: insights into nucleotide specificity, dimerization, and cGMP-dependent conformational change.

Authors:  Clemens C Heikaus; Joseph R Stout; Monica R Sekharan; Catherine M Eakin; Ponni Rajagopal; Peter S Brzovic; Joseph A Beavo; Rachel E Klevit
Journal:  J Biol Chem       Date:  2008-06-04       Impact factor: 5.157

Review 3.  Vardenafil: a review of its use in erectile dysfunction.

Authors:  Gillian M Keating; Lesley J Scott
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 4.  Spotlight on vardenafil in erectile dysfunction.

Authors:  Gillian M Keating; Lesley J Scott
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 5.  Safety and tolerability of oral erectile dysfunction treatments in the elderly.

Authors:  Andrea Salonia; Alberto Briganti; Piero Montorsi; Tommaso Maga; Federico Dehò; Giuseppe Zanni; Bruno Mazzoccoli; Nazareno Suardi; Patrizio Rigatti; Francesco Montorsi
Journal:  Drugs Aging       Date:  2005       Impact factor: 4.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.